Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

Citation:

Marshall AD, Willing AR, Kairouz A, Cunningham EB, Wheeler A, O'Brien N, Perera V, Ward JW, Hiebert L, Degenhardt L, et al. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions. Lancet Gastroenterol Hepatol [Internet]. 2024.